MCID: ALV007
MIFTS: 45

Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins

Categories: Genetic diseases, Fetal diseases, Cardiovascular diseases, Respiratory diseases, Rare diseases

Aliases & Classifications for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

MalaCards integrated aliases for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

Name: Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins 53 24 55 71 36 28 13
Acdmpv 53 24 55 71
Alveolar Capillary Dysplasia 24 71 69
Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins and Other Congenital Anomalies 53 71
Congenital Alveolar Capillary Dysplasia 24 55
Acd 24 71
Alveolar Capillary Dysplasia with Misalignment of Pulmonary Vessels 55
Familial Persistent Pulmonary Hypertension of the Newborn 24
Persistent Fetal Circulation Syndrome 69
Misalignment of the Pulmonary Vessels 24
Acd/mpv 24

Characteristics:

Orphanet epidemiological data:

55
congenital alveolar capillary dysplasia
Inheritance: Autosomal dominant; Prevalence: 1-9/100000 (Canada),<1/1000000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: early childhood;

OMIM:

53
Inheritance:
autosomal dominant

Miscellaneous:
lethal in the neonatal period
features other than acd/mpv are variably present


HPO:

31
alveolar capillary dysplasia with misalignment of pulmonary veins:
Mortality/Aging neonatal death
Inheritance autosomal recessive inheritance autosomal dominant inheritance


Classifications:

Orphanet: 55  
Rare respiratory diseases


Summaries for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

UniProtKB/Swiss-Prot : 71 Alveolar capillary dysplasia with misalignment of pulmonary veins: A rare developmental disorder characterized by abnormal development of the capillary vascular system in the lungs. Histological features include failure of formation and ingrowth of alveolar capillaries, medial muscular thickening of small pulmonary arterioles with muscularization of the intraacinar arterioles, thickened alveolar walls, and anomalously situated pulmonary veins running alongside pulmonary arterioles and sharing the same adventitial sheath. Less common features include a reduced number of alveoli and a patchy distribution of the histopathologic changes. Affected infants present with respiratory distress and the disease is fatal within the newborn period. Additional features include multiple congenital anomalies affecting the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems, as well as disruption of the normal right- left asymmetry of intrathoracic or intraabdominal organs. ACDMPV is a rare cause of persistent pulmonary hypertension of the newborn, an abnormal physiologic state caused by failure of transition of the pulmonary circulation from the high pulmonary vascular resistance of the fetus to the low pulmonary vascular resistance of the newborn.

MalaCards based summary : Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins, also known as acdmpv, is related to alveolar capillary dysplasia and alopecia-contractures-dwarfism mental retardation syndrome, and has symptoms including pulmonary arterial hypertension, patent ductus arteriosus and atrial septal defect. An important gene associated with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins is FOXF1 (Forkhead Box F1). The drugs Benzocaine and Nitric Oxide have been mentioned in the context of this disorder. Affiliated tissues include lung, brain and heart.

Genetics Home Reference : 24 Alveolar capillary dysplasia with misalignment of pulmonary veins (ACD/MPV) is a disorder affecting the development of the lungs and their blood vessels. The disorder affects the millions of small air sacs (alveoli) in the lungs and the tiny blood vessels (capillaries) in the alveoli. It is through these alveolar capillaries that inhaled oxygen enters the bloodstream for distribution throughout the body and carbon dioxide leaves the bloodstream to be exhaled.

OMIM : 53 Congenital alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is characterized histologically by failure of formation and ingrowth of alveolar capillaries that then do not make contact with alveolar epithelium, medial muscular thickening of small pulmonary arterioles with muscularization of the intraacinar arterioles, thickened alveolar walls, and anomalously situated pulmonary veins running alongside pulmonary arterioles and sharing the same adventitial sheath. Less common features include a reduced number of alveoli and a patchy distribution of the histopathologic changes. The disorder is associated with persistent pulmonary hypertension of the neonate and shows varying degrees of lability and severity (Boggs et al., 1994). Affected infants present with respiratory distress resulting from pulmonary hypertension in the early postnatal period, and the disease is uniformly fatal within the newborn period (Vassal et al., 1998). Additional features of ACDMPV include multiple congenital anomalies affecting the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems, as well as disruption of the normal right-left asymmetry of intrathoracic or intraabdominal organs (Sen et al., 2004). (265380)

Related Diseases for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Diseases related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 11, show less)
# Related Disease Score Top Affiliating Genes
1 alveolar capillary dysplasia 31.2 COL18A1 FOXF1 LINC01081
2 alopecia-contractures-dwarfism mental retardation syndrome 11.8
3 dyskeratosis congenita 11.7
4 persistent fetal circulation syndrome 11.5
5 dyskeratosis congenita, autosomal dominant 6 11.3
6 acrofacial dysostosis, catania type 10.2
7 pancreas, annular 10.2
8 hypoplastic left heart syndrome 1 10.2
9 hypoplastic left heart syndrome 10.2
10 acute cholinergic dysautonomia 10.2
11 pulmonary hypertension 9.9

Graphical network of the top 20 diseases related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:



Diseases related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins

Symptoms & Phenotypes for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Symptoms via clinical synopsis from OMIM:

53
Prenatal Manifestations Amniotic Fluid:
polyhydramnios

Genitourinary Kidneys:
hydronephrosis

Respiratory Lung:
abnormal lung lobation

Respiratory:
pulmonary insufficiency

Cardiovascular Heart:
right-to-left shunt via the foramen ovale or ductus arteriosus or both
atrial septal defect (in some patients)

Genitourinary Bladder:
bladder dilatation

Abdomen Gastroin testinal:
intestinal malrotation
duodenal atresia
meckel diverticulum

Genitourinary Ureters:
hydroureter

Abdomen Pancreas:
annular pancreas

Abdomen Biliary Tract:
gallbladder agenesis

Cardiovascular Vascular:
alveolar capillary dysplasia (acd)
malposition of pulmonary vein branches adjacent to pulmonary artery branches (mpv)
deficient capillarization of airspace walls
increased muscularization of arterioles
neonatal pulmonary hypertension


Clinical features from OMIM:

265380

Human phenotypes related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

55 31 (showing 32, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 pulmonary arterial hypertension 55 31 Very frequent (99-80%) HP:0002092
2 patent ductus arteriosus 55 31 Frequent (79-30%) HP:0001643
3 atrial septal defect 55 31 occasional (7.5%) Occasional (29-5%) HP:0001631
4 intestinal malrotation 55 31 Frequent (79-30%) HP:0002566
5 hydronephrosis 55 31 Occasional (29-5%) HP:0000126
6 annular pancreas 55 31 Occasional (29-5%) HP:0001734
7 respiratory distress 55 Very frequent (99-80%)
8 hypertension 31 HP:0000822
9 abnormal vertebral morphology 55 Occasional (29-5%)
10 bicuspid aortic valve 55 Occasional (29-5%)
11 hypoplastic left heart 55 Frequent (79-30%)
12 aganglionic megacolon 55 Occasional (29-5%)
13 anal atresia 55 Occasional (29-5%)
14 polyhydramnios 31 HP:0001561
15 tetralogy of fallot 55 Occasional (29-5%)
16 ventricular septal defect 55 Occasional (29-5%)
17 tracheoesophageal fistula 55 Occasional (29-5%)
18 hydroureter 31 HP:0000072
19 asplenia 55 Occasional (29-5%)
20 atrioventricular canal defect 55 Occasional (29-5%)
21 volvulus 55 Occasional (29-5%)
22 abnormal lung lobation 31 HP:0002101
23 aortic valve stenosis 55 Occasional (29-5%)
24 single umbilical artery 55 Occasional (29-5%)
25 duodenal atresia 31 HP:0002247
26 duodenal stenosis 55 Occasional (29-5%)
27 meckel diverticulum 31 HP:0002245
28 absent gallbladder 55 Occasional (29-5%)
29 abnormality of the pulmonary veins 31 HP:0011718
30 pulmonary insufficiency 31 HP:0010444
31 pulmonary valve atresia 55 Occasional (29-5%)
32 right-to-left shunt 31 HP:0001694

Drugs & Therapeutics for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Drugs for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 53, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved, Investigational Phase 4,Phase 3 1994-09-7, 94-09-7 2337
2
Nitric Oxide Approved Phase 4,Phase 3,Phase 1,Phase 2 10102-43-9 145068
3
Adenosine Approved, Investigational Phase 4 58-61-7 60961
4
Iloprost Approved, Investigational Phase 4,Phase 1,Phase 2 78919-13-8 6443959
5
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 77-92-9 311
6 tannic acid Approved, Nutraceutical Phase 4,Phase 3
7 Pharmaceutical Solutions Phase 4,Phase 3
8 Phosphodiesterase 5 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
9 Phosphodiesterase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
10 Sildenafil Citrate Phase 4,Phase 3,Phase 2,Phase 1 171599-83-0
11 Vasodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
12 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1
13 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1
14 Antioxidants Phase 4,Phase 3,Phase 1,Phase 2
15 Autonomic Agents Phase 4,Phase 3,Phase 1,Phase 2
16 Bronchodilator Agents Phase 4,Phase 3,Phase 1,Phase 2
17 Endothelium-Dependent Relaxing Factors Phase 4,Phase 3,Phase 1,Phase 2
18 Neurotransmitter Agents Phase 4,Phase 3,Phase 1,Phase 2
19 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2
20 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Endothelial Growth Factors Phase 4
22 Mitogens Phase 4
23 Platelet Aggregation Inhibitors Phase 4,Phase 2,Phase 1
24 Citrate Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1
25
Progesterone Approved, Vet_approved Phase 3 57-83-0 5994
26
Bosentan Approved, Investigational Phase 3 147536-97-8 104865
27 Hormone Antagonists Phase 3,Phase 2
28 Hormones Phase 3,Phase 2
29 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
30 11-hydroxyprogesterone Phase 3
31 17-alpha-hydroxy-progesterone caproate Phase 3
32 Estrogen Antagonists Phase 3
33 Estrogens Phase 3
34 Progestins Phase 3
35 Antihypertensive Agents Phase 3,Phase 2
36 Endothelin Receptor Antagonists Phase 3
37 Caproate Nutraceutical Phase 3
38
Betamethasone Approved, Vet_approved Phase 2 378-44-9 9782
39
Treprostinil Approved, Investigational Phase 2 81846-19-7 6918140 54786
40
Milrinone Approved Phase 2 78415-72-2 4197
41 Anti-Inflammatory Agents Phase 2
42 Betamethasone benzoate Phase 2
43 Betamethasone sodium phosphate Phase 2
44 Betamethasone Valerate Phase 2 2152-44-5
45 Betamethasone-17,21-dipropionate Phase 2
46 glucocorticoids Phase 2
47 Antidepressive Agents, Tricyclic Phase 2
48 Tezosentan Phase 2
49 Phosphodiesterase 3 Inhibitors Phase 2
50 Antibodies
51 Immunoglobulins
52 Natriuretic Agents
53 Natriuretic Peptide, Brain

Interventional clinical trials:

(showing 31, show less)

# Name Status NCT ID Phase Drugs
1 Oral Sildenafil in Persistent Pulmonary Hypertension Secondary to Meconium Aspiration Syndrome in Newborns Completed NCT01757782 Phase 4 Oral Sildenafil;Placebo (distilled water)
2 Inhaled Nitric Oxide by Oxygen Hood in Neonates Completed NCT00732537 Phase 4 inhaled Nitric Oxide;Oxygen (>90% by hood) - standard therapy
3 Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure Recruiting NCT01891500 Phase 4 Inhaled nitric oxide;Nitrogen Gas;Crossover iNO
4 Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants. Terminated NCT00409526 Phase 4 Inhaled Iloprost
5 Sildenofil in Persistent Pulmonary Hypertension in Newborns Unknown status NCT01558466 Phase 3 Sildenafil;diluent
6 Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) Completed NCT00099164 Phase 3 17 alpha-hydroxyprogesterone caproate (17P)
7 A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn Recruiting NCT01720524 Phase 3 placebo;iv sildenafil
8 Persistent Pulmonary Hypertension of the Newborn Terminated NCT01389856 Phase 3 Bosentan;Matching placebo
9 Inhaled Nitric Oxide Study for Respiratory Failure in Newborns Terminated NCT00005776 Phase 3 Inhaled nitric oxide;Placebo
10 Early Inhaled Nitric Oxide for Respiratory Failure in Newborns Terminated NCT00005773 Phase 3 Inhaled Nitric Oxide;Standard iNO therapy
11 Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants Unknown status NCT01206946 Phase 2 Betamethasone
12 A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) Completed NCT01801982 Phase 2
13 Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn Recruiting NCT02261883 Phase 2 IV Remodulin;Placebo
14 Milrinone in Congenital Diaphragmatic Hernia Recruiting NCT02951130 Phase 2 Milrinone;Placebo (5% Dextrose)
15 Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) Terminated NCT01069861 Phase 2 sildanefil
16 IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn Withdrawn NCT01360671 Phase 2 Sildenafil
17 Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients Withdrawn NCT00981591 Phase 1, Phase 2 Iloprost;Placebo
18 Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure Withdrawn NCT00598429 Phase 2 Inhaled Prostaglandin E1
19 Pharmacokinetics of Sildenafil in Premature Infants Completed NCT01670136 Phase 1 1 dose of sildenafil
20 Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension Unknown status NCT01373749 NO inhalation;NO inhalation continued with sildenafil
21 Circulatory Changes During Venovenous (VV)- and Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO) Unknown status NCT00622492
22 Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study Completed NCT01203423
23 NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn Completed NCT00139217 iNO
24 Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children Completed NCT00005323
25 Risk Factors for Pulmonary Hypertension of the Newborn Completed NCT00005497
26 Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO Completed NCT00371241
27 PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn Recruiting NCT00710177
28 Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN Recruiting NCT02940327
29 Plethismographic Perfusion Index in Neonates Recruiting NCT02380040
30 Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn Terminated NCT01088997 Milrinone Lactate
31 N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension Terminated NCT00443859

Search NIH Clinical Center for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Genetic Tests for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Genetic tests related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

# Genetic test Affiliating Genes
1 Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins 28 FOXF1

Anatomical Context for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

MalaCards organs/tissues related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

38
Lung, Brain, Heart, Pancreas, Endothelial, Eye

Publications for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Articles related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

(showing 15, show less)
# Title Authors Year
1
A Novel De Novo Pathogenic Variant in FOXF1 in a Newborn with Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins. ( 28332379 )
2017
2
Pathogenetics of alveolar capillary dysplasia with misalignment of pulmonary veins. ( 27071622 )
2016
3
Maternal somatic mosaicism of FOXF1 mutation causes recurrent alveolar capillary dysplasia with misalignment of pulmonary veins in siblings. ( 27109257 )
2016
4
Recurrence of alveolar capillary dysplasia with misalignment of pulmonary veins in two consecutive siblings. ( 26484320 )
2015
5
Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins. ( 25052575 )
2014
6
Comparative analyses of lung transcriptomes in patients with alveolar capillary dysplasia with misalignment of pulmonary veins and in foxf1 heterozygous knockout mice. ( 24722050 )
2014
7
Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. ( 24842713 )
2014
8
A familial case of alveolar capillary dysplasia with misalignment of pulmonary veins supports paternal imprinting of FOXF1 in human. ( 22990143 )
2013
9
A novel mutation in FOXF1 gene associated with alveolar capillary dysplasia with misalignment of pulmonary veins, intestinal malrotation and annular pancreas. ( 23407133 )
2013
10
Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACD/MPV): A Case Series. ( 24829819 )
2013
11
Alveolar capillary dysplasia with misalignment of pulmonary veins with a wide spectrum of extrapulmonary manifestations. ( 24147432 )
2013
12
Novel FOXF1 deep intronic deletion causes lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary veins. ( 23943206 )
2013
13
Inversion upstream of FOXF1 in a case of lethal alveolar capillary dysplasia with misalignment of pulmonary veins. ( 23444129 )
2013
14
Alveolar capillary dysplasia with misalignment of pulmonary veins and anterior segment dysgenesis of the eye: a report of a new association and review of the literature. ( 11536028 )
2001
15
Congenital alveolar capillary dysplasia with misalignment of pulmonary veins associated with hypoplastic left heart syndrome. ( 11178633 )
2001

Variations for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

UniProtKB/Swiss-Prot genetic disease variations for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

71 (showing 20, show less)
# Symbol AA change Variation ID SNP ID
1 FOXF1 p.Pro49Gln VAR_071016
2 FOXF1 p.Pro49Ser VAR_071017
3 FOXF1 p.Ser52Phe VAR_071018
4 FOXF1 p.Tyr53Cys VAR_071019
5 FOXF1 p.Ile74Asn VAR_071020
6 FOXF1 p.Phe85Ile VAR_071021
7 FOXF1 p.Phe85Leu VAR_071022
8 FOXF1 p.Phe85Ser VAR_071023
9 FOXF1 p.Arg86Trp VAR_071024
10 FOXF1 p.Gly91Glu VAR_071025
11 FOXF1 p.Gly91Val VAR_071026
12 FOXF1 p.Val96Met VAR_071027
13 FOXF1 p.Arg97His VAR_071028
14 FOXF1 p.His98Gln VAR_071029
15 FOXF1 p.Ser101Leu VAR_071030
16 FOXF1 p.Phe106Leu VAR_071031
17 FOXF1 p.Gly119Asp VAR_071033
18 FOXF1 p.Pro126Leu VAR_071034
19 FOXF1 p.Arg139Leu VAR_071035
20 FOXF1 p.Phe77Leu VAR_076592

ClinVar genetic disease variations for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins:

6 (showing 4, show less)
# Gene Variation Type Significance SNP ID Assembly Location
1 FOXF1 NM_001451.2(FOXF1): c.225C> A (p.Tyr75Ter) single nucleotide variant Pathogenic rs121909336 GRCh37 Chromosome 16, 86544400: 86544400
2 FOXF1 NM_001451.2(FOXF1): c.1138T> C (p.Ter380Arg) single nucleotide variant Pathogenic rs121909337 GRCh37 Chromosome 16, 86546689: 86546689
3 FOXF1 FOXF1, 1-BP DUP, 775T duplication Pathogenic
4 FOXF1 FOXF1, 2-BP DEL, 956TT deletion Pathogenic

Expression for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Search GEO for disease gene expression data for Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins.

Pathways for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

GO Terms for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

Biological processes related to Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.16 COL18A1 FOXF1
2 positive regulation of cell migration GO:0030335 8.96 COL18A1 FOXF1
3 animal organ morphogenesis GO:0009887 8.62 COL18A1 FOXF1

Sources for Alveolar Capillary Dysplasia with Misalignment of Pulmonary...

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....